MedTrace Logo

Tobacco Approach Avoidance Training for Adolescent Smokers-2

NCT01625637 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2014-01-20

No results posted yet for this study

Summary

This is a two part study. In Study 2, smokers who want to quit smoking will participate in a 4 week smoking cessation program combining weekly cognitive behavioral therapy (CBT) with weekly regular-AAT or placebo-AAT training. We hypothesize that adolescent smokers will exhibit stronger approach tendencies towards smoking-related stimuli in the tobacco Approach Avoidance Training (AAT) task when compared with nonsmokers and that adolescent smokers who are trained to avoid smoking related stimuli using the AAT will avoid tobacco approach tendencies in the AAT test trials and the Implicit Association Task, when compared to adolescent smokers who are not exposed to AAT training. We also hypothesize that adolescent smokers who are trained to avoid tobacco in a training AAT in combination with CBT will have better abstinence rates compared to those who receive placebo AAT training with CBT.

Conditions

  • Tobacco Use Disorder

Interventions

BEHAVIORAL

AAT-experiment

This AAT condition trains kids to avoid cigarettes

BEHAVIORAL

AAT-placebo

This AAT condition is a no contingency continued assessment version (50% approach-cigarettes, 50% avoid cigarettes).

Sponsors & Collaborators

  • VU University of Amsterdam

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Suchitra Krishnan-Sarin, Ph.D. · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-05-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01625637 on ClinicalTrials.gov